<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2524-177X</journal-id>
<journal-title><![CDATA[Revista médica del Hospital General de México]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. med. Hosp. Gen. Méx.]]></abbrev-journal-title>
<issn>2524-177X</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Médica del Hospital General de México A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2524-177X2019000100033</article-id>
<article-id pub-id-type="doi">10.24875/hgmx.m19000001</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Genomic studies in epilepsy]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guzmán-Jiménez]]></surname>
<given-names><![CDATA[Diana E.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Flores-Ramírez]]></surname>
<given-names><![CDATA[Erika L.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Velasco-Monroy]]></surname>
<given-names><![CDATA[Ana L.]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Nacional Autónoma de México Programa de Doctorado en Ciencias Biomédicas ]]></institution>
<addr-line><![CDATA[Mexico City ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital General de México Clinica de Epilepsia, Unidad de Neurocirugía Funcional y Estereotaxia Unidad de Neurología y Neurocirugía]]></institution>
<addr-line><![CDATA[Mexico City ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Nacional Autónoma de Guadalajara Estudiante de Servivio Social en Investigación ]]></institution>
<addr-line><![CDATA[Jalisco ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2019</year>
</pub-date>
<volume>82</volume>
<numero>1</numero>
<fpage>33</fpage>
<lpage>38</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2524-177X2019000100033&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2524-177X2019000100033&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2524-177X2019000100033&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Epilepsy is a progressive and disabling disease if not diagnosed early; for this reason, it has been the subject of research, specially in cases with idiopathic etiology. Approximately between 1 and 2% of the world population have epilepsy. In Mexico the prevalence is from 10 to 20 patients per 1000 inhabitants. Lately, the scientific community has been trying to create, adapt, and use biomolecular tools to study its pathophysiology so that, hopefully, in a near future we are able to intervene in the natural history of this disease. The aim of this work is to cite evidence about some of the molecular biology techniques in order to support and encourage investment in neurogenomical research; as a necessary tool in the study of epilepsy.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Epilepsy]]></kwd>
<kwd lng="en"><![CDATA[Biomolecular Tools]]></kwd>
<kwd lng="en"><![CDATA[Neurogenomics]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fisher]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Acevedo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Arzimanoglou]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ILAE official report:a practical clinical definition of epilepsy]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2014</year>
<volume>55</volume>
<page-range>475-82</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<source><![CDATA[OMS, Organización Mundial de la Salud]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<collab>Programa Prioritario de Epilepsia</collab>
<source><![CDATA[Frecuencia en México]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<source><![CDATA[Epilpsy Society]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Mefford]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Advancing epilepsy genetics in the genomic era]]></article-title>
<source><![CDATA[Genome Med]]></source>
<year>2015</year>
<volume>7</volume>
<page-range>91</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lennox]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The heredity of epilepsy as told by relatives and twins]]></article-title>
<source><![CDATA[J Am Med Assoc]]></source>
<year>1951</year>
<volume>146</volume>
<page-range>529-36</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Watson]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Crick]]></surname>
<given-names><![CDATA[FH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Molecular structure of nucleic acids;A structure for deoxyribose nucleic acid]]></article-title>
<source><![CDATA[Nature]]></source>
<year>1953</year>
<volume>171</volume>
<page-range>737-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<source><![CDATA[Genomics and World Health:report of the Advisory Committee on Health Research]]></source>
<year>2002</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wan]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predictive rule inference for epistatic interaction detection in genome-wide association studies]]></article-title>
<source><![CDATA[Bioinformatics]]></source>
<year>2010</year>
<volume>26</volume>
<page-range>30-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<collab>International League Against Epilepsy Consortium on Complex Epilepsies</collab>
<article-title xml:lang=""><![CDATA[Genetic determinants of common epilepsies:a meta-analysis of genome-wide association studies]]></article-title>
<source><![CDATA[Lancet Neurol]]></source>
<year>2014</year>
<volume>13</volume>
<page-range>893-903</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feenstra]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Pasternak]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Geller]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Common variants associated with general and MMR vaccine-related febrile seizures]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2014</year>
<volume>46</volume>
<page-range>1274-82</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hastings]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lupski]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenberg]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Ira]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mechanisms of change in gene copy number]]></article-title>
<source><![CDATA[Nat Rev Genet]]></source>
<year>2009</year>
<volume>10</volume>
<page-range>551-64</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Olson]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Avallone]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Copy number variation plays an important role in clinical epilepsy]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2014</year>
<volume>75</volume>
<page-range>943-58</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mefford]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Yendle]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rare copy number variants are an important cause of epileptic encephalopathies]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2011</year>
<volume>70</volume>
<page-range>974-85</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Helbig]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Swinkels]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Aten]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Structural genomic variation in childhood epilepsies with complex phenotypes]]></article-title>
<source><![CDATA[Eur J Hum Genet]]></source>
<year>2014</year>
<volume>22</volume>
<page-range>896-901</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mefford]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Muhle]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ostertag]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genome-wide copy number variation in epilepsy:novel susceptibility loci in idiopathic generalized and focal epilepsies]]></article-title>
<source><![CDATA[PLoS Genet]]></source>
<year>2010</year>
<volume>6</volume>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heinzen]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Radtke]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Urban]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2010</year>
<volume>86</volume>
<page-range>707-18</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez-Escrig]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gobernado]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Herranz]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Secuenciación de genoma completo:un salto cualitativo en los estudios genéticos]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2012</year>
<volume>54</volume>
<page-range>692-8</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Pagnamenta]]></surname>
<given-names><![CDATA[AT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis]]></article-title>
<source><![CDATA[Hum Mol Genet]]></source>
<year>2014</year>
<volume>23</volume>
<page-range>3200-11</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Turner]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Shendure]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Targeted capture and massively parallel sequencing of the human exome]]></article-title>
<source><![CDATA[J Investig Med]]></source>
<year>2010</year>
<volume>58</volume>
<page-range>123</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Helbig]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Farwell Hagman]]></surname>
<given-names><![CDATA[KD]]></given-names>
</name>
<name>
<surname><![CDATA[Shinde]]></surname>
<given-names><![CDATA[DN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic exome sequencing provides a molecular diagnosis for a significant proportion of patients with epilepsy]]></article-title>
<source><![CDATA[Genet Med]]></source>
<year>2016</year>
<volume>18</volume>
<page-range>898-905</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Møller]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Dahl]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Helbig]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The contribution of next generation sequencing to epilepsy genetics]]></article-title>
<source><![CDATA[Expert Rev Mol Diagn]]></source>
<year>2015</year>
<volume>15</volume>
<page-range>1531-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="">
<collab>The ILAE Genetics Commission Blog</collab>
<source><![CDATA[Beyond the Ion Channel]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="">
<source><![CDATA[Gene Cards]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baulac]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genetics advances in autosomal dominant focal epilepsies:focus on DEPDC5]]></article-title>
<source><![CDATA[Prog Brain Res]]></source>
<year>2014</year>
<volume>213</volume>
<page-range>123-39</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Labate]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gambardella]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Andermann]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benign mesial temporal lobe epilepsy]]></article-title>
<source><![CDATA[Nat Rev Neurol]]></source>
<year>2011</year>
<volume>7</volume>
<page-range>237-40</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Milligan]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gazina]]></surname>
<given-names><![CDATA[EV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2014</year>
<volume>75</volume>
<page-range>581-90</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pierson]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Yuan]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Marsh]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GRIN2A mutation and early-onset epileptic encephalopathy:personalized therapy with memantine]]></article-title>
<source><![CDATA[Ann Clin Transl Neurol]]></source>
<year>2014</year>
<volume>1</volume>
<page-range>190-8</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Skjei]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Church]]></surname>
<given-names><![CDATA[EW]]></given-names>
</name>
<name>
<surname><![CDATA[Harding]]></surname>
<given-names><![CDATA[BN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy]]></article-title>
<source><![CDATA[J Neurosurg Pediatr]]></source>
<year>2015</year>
<volume>16</volume>
<page-range>668-74</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kovac]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recent advances in epilepsy]]></article-title>
<source><![CDATA[J Neurol]]></source>
<year>2014</year>
<volume>261</volume>
<page-range>837-41</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ortiz-Vilchis]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Modelos experimentales en optogenética y su aplicación en enfermedades neurodegenerativas motoras]]></article-title>
<source><![CDATA[Rev Med Inv]]></source>
<year>2015</year>
<volume>3</volume>
<page-range>107-68</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lopes-Cendes]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ribeiro]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspectos genéticos de las epilepsias:una visión actualizada]]></article-title>
<source><![CDATA[Rev Méd Clín Las Condes]]></source>
<year>2013</year>
<volume>24</volume>
<page-range>909-14</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de]]></surname>
<given-names><![CDATA[Ligt J]]></given-names>
</name>
<name>
<surname><![CDATA[Willemsen]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[van]]></surname>
<given-names><![CDATA[Bon BW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnostic exome sequencing in persons with severe intellectual disability]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2012</year>
<volume>367</volume>
<page-range>1921-9</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dimassi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Labalme]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ville]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndrome]]></article-title>
<source><![CDATA[Clin Genet]]></source>
<year>2016</year>
<volume>89</volume>
<page-range>198-204</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[AS]]></given-names>
</name>
</person-group>
<collab>Epi4K Consortium, Epilepsy Phenome/Genome Project</collab>
<article-title xml:lang=""><![CDATA[De novo mutations in epileptic encephalopathies]]></article-title>
<source><![CDATA[Nature]]></source>
<year>2013</year>
<volume>501</volume>
<page-range>217-21</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Michaud]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Lachance]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hamdan]]></surname>
<given-names><![CDATA[FF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The genetic landscape of infantile spasms]]></article-title>
<source><![CDATA[Hum Mol Genet]]></source>
<year>2014</year>
<volume>23</volume>
<page-range>4846-58</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Møller]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Dahl]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[Helbig]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The contribution of next generation sequencing to epilepsy genetics]]></article-title>
<source><![CDATA[Expert Rev Mol Diagn]]></source>
<year>2015</year>
<volume>15</volume>
<page-range>1531-8</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Timal]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hoischen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lehle]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gene identification in the congenital disorders of glycosylation Type I by whole-exome sequencing]]></article-title>
<source><![CDATA[Hum Mol Genet]]></source>
<year>2012</year>
<volume>21</volume>
<page-range>4151-61</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harvey]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Duguid]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
<name>
<surname><![CDATA[Alldred]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The GDP-GTP exchange factor collybistin:an essential determinant of neuronal gephyrin clustering]]></article-title>
<source><![CDATA[J Neurosci]]></source>
<year>2004</year>
<volume>24</volume>
<page-range>5816-26</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lesca]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Till]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Labalme]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vallee]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo xq11.11 microdeletion including ARHGEF9 in a boy with mental retardation, epilepsy, macrosomia, and dysmorphic features]]></article-title>
<source><![CDATA[Am J Med Genet A]]></source>
<year>2011</year>
<volume>155A</volume>
<page-range>1706-11</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lesca]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Depienne]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epilepsy genetics:the ongoing revolution]]></article-title>
<source><![CDATA[Rev Neurol]]></source>
<year>2015</year>
<volume>171</volume>
<page-range>539-57</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shimojima]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Sugawara]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Shichiji]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Loss-of-function mutation of collybistin is responsible for X-linked mental retardation associated with epilepsy]]></article-title>
<source><![CDATA[J Hum Genet]]></source>
<year>2011</year>
<volume>56</volume>
<page-range>561-5</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bruyere]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Lewis]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wood]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[MacLeod]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Langlois]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Confirmation of linkage in X-linked infantile spasms (West syndrome) and refinement of the disease locus to xp21.3-xp22.1]]></article-title>
<source><![CDATA[Clin Genet]]></source>
<year>1999</year>
<volume>55</volume>
<page-range>173-81</page-range></nlm-citation>
</ref>
<ref id="B44">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Claes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Devriendt]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lagae]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The X-linked infantile spasms syndrome (MIM 308350) maps to xp11.4-xpter in two pedigrees]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>1997</year>
<volume>42</volume>
<page-range>360-4</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feinberg]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Leahy]]></surname>
<given-names><![CDATA[WR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Infantile spasms:case report of sex-linked inheritance]]></article-title>
<source><![CDATA[Dev Med Child Neurol]]></source>
<year>1977</year>
<volume>19</volume>
<page-range>524-6</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fullston]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Brueton]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Willis]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ohtahara syndrome in a family with an ARX protein truncation mutation (c.81C&gt;G/p.Y27X)]]></article-title>
<source><![CDATA[Eur J Hum Genet]]></source>
<year>2010</year>
<volume>18</volume>
<page-range>157-62</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giordano]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sartori]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Russo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Familial ohtahara syndrome due to a novel ARX gene mutation]]></article-title>
<source><![CDATA[Am J Med Genet A]]></source>
<year>2010</year>
<volume>152A</volume>
<page-range>3133-7</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kato]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Das]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Petras]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations of ARX are associated with striking pleiotropy and consistent genotype-phenotype correlation]]></article-title>
<source><![CDATA[Hum Mutat]]></source>
<year>2004</year>
<volume>23</volume>
<page-range>147-59</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kato]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Saitoh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kamei]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome)]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2007</year>
<volume>81</volume>
<page-range>361-6</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poeta]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Fusco]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Drongitis]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A regulatory path associated with X-linked intellectual disability and epilepsy links KDM5C to the polyalanine expansions in ARX]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2013</year>
<volume>92</volume>
<page-range>114-25</page-range></nlm-citation>
</ref>
<ref id="B51">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Proud]]></surname>
<given-names><![CDATA[VK]]></given-names>
</name>
<name>
<surname><![CDATA[Levine]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Carpenter]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[New X-linked syndrome with seizures, acquired micrencephaly, and agenesis of the corpus callosum]]></article-title>
<source><![CDATA[Am J Med Genet]]></source>
<year>1992</year>
<volume>43</volume>
<page-range>458-66</page-range></nlm-citation>
</ref>
<ref id="B52">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strømme]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Mangelsdorf]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Shaw]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in the human ortholog of aristaless cause X-linked mental retardation and epilepsy]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2002</year>
<volume>30</volume>
<page-range>441-5</page-range></nlm-citation>
</ref>
<ref id="B53">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strømme]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sundet]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Mørk]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[X linked mental retardation and infantile spasms in a family:new clinical data and linkage to xp11.4-xp22.11]]></article-title>
<source><![CDATA[J Med Genet]]></source>
<year>1999</year>
<volume>36</volume>
<page-range>374-8</page-range></nlm-citation>
</ref>
<ref id="B54">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turner]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Partington]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Kerr]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mangelsdorf]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gecz]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation]]></article-title>
<source><![CDATA[Am J Med Genet]]></source>
<year>2002</year>
<volume>112</volume>
<page-range>405-11</page-range></nlm-citation>
</ref>
<ref id="B55">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[YC]]></given-names>
</name>
<name>
<surname><![CDATA[Burgunder]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Wilder-Smith]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Electroencephalographic changes and seizures in familial hemiplegic migraine patients with the CACNA1A gene S218L mutation]]></article-title>
<source><![CDATA[J Clin Neurosci]]></source>
<year>2008</year>
<volume>15</volume>
<page-range>891-4</page-range></nlm-citation>
</ref>
<ref id="B56">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chioza]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Wilkie]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nashef]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between the alpha(1a) calcium channel gene CACNA1A and idiopathic generalized epilepsy]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2001</year>
<volume>56</volume>
<page-range>1245-6</page-range></nlm-citation>
</ref>
<ref id="B57">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Holtmann]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Opp]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Tokarzewski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Korn-Merker]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human epilepsy, episodic ataxia Type 2, and migraine]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2002</year>
<volume>359</volume>
<page-range>170-1</page-range></nlm-citation>
</ref>
<ref id="B58">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jouvenceau]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Eunson]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Spauschus]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2001</year>
<volume>358</volume>
<page-range>801-7</page-range></nlm-citation>
</ref>
<ref id="B59">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kors]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Melberg]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vanmolkot]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2004</year>
<volume>63</volume>
<page-range>1136-7</page-range></nlm-citation>
</ref>
<ref id="B60">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pan]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Association between genetic variation of CACNA1H and childhood absence epilepsy]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2003</year>
<volume>54</volume>
<page-range>239-43</page-range></nlm-citation>
</ref>
<ref id="B61">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Khosravani]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Varela]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2007</year>
<volume>62</volume>
<page-range>560-8</page-range></nlm-citation>
</ref>
<ref id="B62">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khosravani]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Altier]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Simms]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gating effects of mutations in the cav3.2 T-type calcium channel associated with childhood absence epilepsy]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>2004</year>
<volume>279</volume>
<page-range>9681-4</page-range></nlm-citation>
</ref>
<ref id="B63">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khosravani]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bladen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Parker]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effects of cav3.2 channel mutations linked to idiopathic generalized epilepsy]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2005</year>
<volume>57</volume>
<page-range>745-9</page-range></nlm-citation>
</ref>
<ref id="B64">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vitko]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Functional characterization and neuronal modeling of the effects of childhood absence epilepsy variants of CACNA1H, a T-type calcium channel]]></article-title>
<source><![CDATA[J Neurosci]]></source>
<year>2005</year>
<volume>25</volume>
<page-range>4844-55</page-range></nlm-citation>
</ref>
<ref id="B65">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mefford]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Yendle]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rare copy number variants are an important cause of epileptic encephalopathies]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2011</year>
<volume>70</volume>
<page-range>974-85</page-range></nlm-citation>
</ref>
<ref id="B66">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vergult]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dheedene]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Meurs]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genomic aberrations of the CACNA2D1 gene in three patients with epilepsy and intellectual disability]]></article-title>
<source><![CDATA[Eur J Hum Genet]]></source>
<year>2015</year>
<volume>23</volume>
<page-range>628-32</page-range></nlm-citation>
</ref>
<ref id="B67">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Archer]]></surname>
<given-names><![CDATA[HL]]></given-names>
</name>
<name>
<surname><![CDATA[Evans]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Edwards]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients]]></article-title>
<source><![CDATA[J Med Genet]]></source>
<year>2006</year>
<volume>43</volume>
<page-range>729-34</page-range></nlm-citation>
</ref>
<ref id="B68">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elia]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Falco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ferri]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CDKL5 mutations in boys with severe encephalopathy and early-onset intractable epilepsy]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2008</year>
<volume>71</volume>
<page-range>997-9</page-range></nlm-citation>
</ref>
<ref id="B69">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bartnik]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Derwi&#324;ska]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gos]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early-onset seizures due to mosaic exonic deletions of CDKL5 in a male and two females]]></article-title>
<source><![CDATA[Genet Med]]></source>
<year>2011</year>
<volume>13</volume>
<page-range>447-52</page-range></nlm-citation>
</ref>
<ref id="B70">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Erez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alu-specific microhomology-mediated deletions in CDKL5 in females with early-onset seizure disorder]]></article-title>
<source><![CDATA[Neurogenetics]]></source>
<year>2009</year>
<volume>10</volume>
<page-range>363-9</page-range></nlm-citation>
</ref>
<ref id="B71">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalscheuer]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
<name>
<surname><![CDATA[Tao]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Donnelly]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2003</year>
<volume>72</volume>
<page-range>1401-11</page-range></nlm-citation>
</ref>
<ref id="B72">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nectoux]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Tallot]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Chelly]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bienvenu]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Maternal origin of a novel C-terminal truncation mutation in CDKL5 causing a severe atypical form of rett syndrome]]></article-title>
<source><![CDATA[Clin Genet]]></source>
<year>2006</year>
<volume>70</volume>
<page-range>29-33</page-range></nlm-citation>
</ref>
<ref id="B73">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nemos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lambert]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Giuliano]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutational spectrum of CDKL5 in early-onset encephalopathies:a study of a large collection of French patients and review of the literature]]></article-title>
<source><![CDATA[Clin Genet]]></source>
<year>2009</year>
<volume>76</volume>
<page-range>357-71</page-range></nlm-citation>
</ref>
<ref id="B74">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rademacher]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hambrock]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fischer]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identification of a novel CDKL5 exon and pathogenic mutations in patients with severe mental retardation, early-onset seizures and rett-like features]]></article-title>
<source><![CDATA[Neurogenetics]]></source>
<year>2011</year>
<volume>12</volume>
<page-range>165-7</page-range></nlm-citation>
</ref>
<ref id="B75">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosas-Vargas]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bahi-Buisson]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Philippe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impairment of CDKL5 nuclear localisation as a cause for severe infantile encephalopathy]]></article-title>
<source><![CDATA[J Med Genet]]></source>
<year>2008</year>
<volume>45</volume>
<page-range>172-8</page-range></nlm-citation>
</ref>
<ref id="B76">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Russo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Marchi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cogliati]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel mutations in the CDKL5 gene, predicted effects and associated phenotypes]]></article-title>
<source><![CDATA[Neurogenetics]]></source>
<year>2009</year>
<volume>10</volume>
<page-range>241-50</page-range></nlm-citation>
</ref>
<ref id="B77">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saletti]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Canafoglia]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cambiaso]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A CDKL5 mutated child with precocious puberty]]></article-title>
<source><![CDATA[Am J Med Genet A]]></source>
<year>2009</year>
<volume>149A</volume>
<page-range>1046-51</page-range></nlm-citation>
</ref>
<ref id="B78">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scala]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Ariani]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Mari]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CDKL5/STK9 is mutated in rett syndrome variant with infantile spasms]]></article-title>
<source><![CDATA[J Med Genet]]></source>
<year>2005</year>
<volume>42</volume>
<page-range>103-7</page-range></nlm-citation>
</ref>
<ref id="B79">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tao]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Van]]></surname>
<given-names><![CDATA[Esch H]]></given-names>
</name>
<name>
<surname><![CDATA[Hagedorn-Greiwe]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5/STK9) gene are associated with severe neurodevelopmental retardation]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2004</year>
<volume>75</volume>
<page-range>1149-54</page-range></nlm-citation>
</ref>
<ref id="B80">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van]]></surname>
<given-names><![CDATA[Esch H]]></given-names>
</name>
<name>
<surname><![CDATA[Jansen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bauters]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Froyen]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Fryns]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Encephalopathy and bilateral cataract in a boy with an interstitial deletion of xp22 comprising the CDKL5 and NHS genes]]></article-title>
<source><![CDATA[Am J Med Genet A]]></source>
<year>2007</year>
<volume>143</volume>
<page-range>364-9</page-range></nlm-citation>
</ref>
<ref id="B81">
<label>49</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weaving]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Christodoulou]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Williamson]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2004</year>
<volume>75</volume>
<page-range>1079-93</page-range></nlm-citation>
</ref>
<ref id="B82">
<label>50</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvill]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Heavin]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Yendle]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2013</year>
<volume>45</volume>
<page-range>825-30</page-range></nlm-citation>
</ref>
<ref id="B83">
<label>51</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chénier]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Yoon]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Argiropoulos]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems]]></article-title>
<source><![CDATA[J Neurodev Disord]]></source>
<year>2014</year>
<volume>6</volume>
<page-range>9</page-range></nlm-citation>
</ref>
<ref id="B84">
<label>52</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galizia]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[CT]]></given-names>
</name>
<name>
<surname><![CDATA[Leu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CHD2 variants are a risk factor for photosensitivity in epilepsy]]></article-title>
<source><![CDATA[Brain]]></source>
<year>2015</year>
<volume>138</volume>
<page-range>1198-207</page-range></nlm-citation>
</ref>
<ref id="B85">
<label>53</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Yusufzai]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Human CHD2 is a chromatin assembly ATPase regulated by its chromo-and DNA-binding domains]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>2015</year>
<volume>290</volume>
<page-range>25-34</page-range></nlm-citation>
</ref>
<ref id="B86">
<label>54</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lund]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Brodtkorb]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Øye]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Røsby]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Selmer]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CHD2 mutations in lennox-gastaut syndrome]]></article-title>
<source><![CDATA[Epilepsy Behav]]></source>
<year>2014</year>
<volume>33</volume>
<page-range>18-21</page-range></nlm-citation>
</ref>
<ref id="B87">
<label>55</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rauch]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Wieczorek]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Graf]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability:an exome sequencing study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2012</year>
<volume>380</volume>
<page-range>1674-82</page-range></nlm-citation>
</ref>
<ref id="B88">
<label>56</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suls]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Jaehn]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Kecskés]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with dravet syndrome]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2013</year>
<volume>93</volume>
<page-range>967-75</page-range></nlm-citation>
</ref>
<ref id="B89">
<label>57</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Carvill]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CHD2 myoclonic encephalopathy is frequently associated with self-induced seizures]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2015</year>
<volume>84</volume>
<page-range>951-8</page-range></nlm-citation>
</ref>
<ref id="B90">
<label>58</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trivisano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Striano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sartorelli]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[CHD2 mutations are a rare cause of generalized epilepsy with myoclonic-atonic seizures]]></article-title>
<source><![CDATA[Epilepsy Behav]]></source>
<year>2015</year>
<volume>51</volume>
<page-range>53-6</page-range></nlm-citation>
</ref>
<ref id="B91">
<label>59</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dibbens]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Mullen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Helbig]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy:precedent for disorders with complex inheritance]]></article-title>
<source><![CDATA[Hum Mol Genet]]></source>
<year>2009</year>
<volume>18</volume>
<page-range>3626-31</page-range></nlm-citation>
</ref>
<ref id="B92">
<label>60</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Helbig]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Mefford]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Sharp]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[15q13.3 microdeletions increase risk of idiopathic generalized epilepsy]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2009</year>
<volume>41</volume>
<page-range>160-2</page-range></nlm-citation>
</ref>
<ref id="B93">
<label>61</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Peñagarikano]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Abrahams]]></surname>
<given-names><![CDATA[BS]]></given-names>
</name>
<name>
<surname><![CDATA[Herman]]></surname>
<given-names><![CDATA[EI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits]]></article-title>
<source><![CDATA[Cell]]></source>
<year>2011</year>
<volume>147</volume>
<page-range>235-46</page-range></nlm-citation>
</ref>
<ref id="B94">
<label>62</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strauss]]></surname>
<given-names><![CDATA[KA]]></given-names>
</name>
<name>
<surname><![CDATA[Puffenberger]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
<name>
<surname><![CDATA[Huentelman]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2006</year>
<volume>354</volume>
<page-range>1370-7</page-range></nlm-citation>
</ref>
<ref id="B95">
<label>63</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alakurtti]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rinne]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations]]></article-title>
<source><![CDATA[Eur J Hum Genet]]></source>
<year>2005</year>
<volume>13</volume>
<page-range>208-15</page-range></nlm-citation>
</ref>
<ref id="B96">
<label>64</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bespalova]]></surname>
<given-names><![CDATA[IN]]></given-names>
</name>
<name>
<surname><![CDATA[Adkins]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Pranzatelli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Burmeister]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel cystatin B mutation and diagnostic PCR assay in an unverricht-lundborg progressive myoclonus epilepsy patient]]></article-title>
<source><![CDATA[Am J Med Genet]]></source>
<year>1997</year>
<volume>74</volume>
<page-range>467-71</page-range></nlm-citation>
</ref>
<ref id="B97">
<label>65</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de]]></surname>
<given-names><![CDATA[Haan GJ]]></given-names>
</name>
<name>
<surname><![CDATA[Halley]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Doelman]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Univerricht-lundborg (sic) disease:underdiagnosed in the Netherlands]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2004</year>
<volume>45</volume>
<page-range>1061-3</page-range></nlm-citation>
</ref>
<ref id="B98">
<label>66</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Di]]></surname>
<given-names><![CDATA[Giaimo R]]></given-names>
</name>
<name>
<surname><![CDATA[Riccio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Santi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[New insights into the molecular basis of progressive myoclonus epilepsy:a multiprotein complex with cystatin B]]></article-title>
<source><![CDATA[Hum Mol Genet]]></source>
<year>2002</year>
<volume>11</volume>
<page-range>2941-50</page-range></nlm-citation>
</ref>
<ref id="B99">
<label>67</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lafrenière]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Rochefort]]></surname>
<given-names><![CDATA[DL]]></given-names>
</name>
<name>
<surname><![CDATA[Chrétien]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Unstable insertion in the 5'flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy Type 1, EPM1]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>1997</year>
<volume>15</volume>
<page-range>298-302</page-range></nlm-citation>
</ref>
<ref id="B100">
<label>68</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lalioti]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Mirotsou]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Buresi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identification of mutations in cystatin B, the gene responsible for the unverricht-lundborg type of progressive myoclonus epilepsy (EPM1)]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>1997</year>
<volume>60</volume>
<page-range>342-51</page-range></nlm-citation>
</ref>
<ref id="B101">
<label>69</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mazarib]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Xiong]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Neufeld]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Unverricht-lundborg disease in a five-generation arab family:instability of dodecamer repeats]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2001</year>
<volume>57</volume>
<page-range>1050-4</page-range></nlm-citation>
</ref>
<ref id="B102">
<label>70</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pennacchio]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Lehesjoki]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Stone]]></surname>
<given-names><![CDATA[NE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1)]]></article-title>
<source><![CDATA[Science]]></source>
<year>1996</year>
<volume>271</volume>
<page-range>1731-4</page-range></nlm-citation>
</ref>
<ref id="B103">
<label>71</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Virtaneva]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[D'Amato]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Miao]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>1997</year>
<volume>15</volume>
<page-range>393-6</page-range></nlm-citation>
</ref>
<ref id="B104">
<label>72</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baulac]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ishida]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Marsan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2015</year>
<volume>77</volume>
<page-range>675-83</page-range></nlm-citation>
</ref>
<ref id="B105">
<label>73</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berkovic]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Serratosa]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Familial partial epilepsy with variable foci:clinical features and linkage to chromosome 22q12]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2004</year>
<volume>45</volume>
<page-range>1054-60</page-range></nlm-citation>
</ref>
<ref id="B106">
<label>74</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Callenbach]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[van den Maagdenberg]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Hottenga]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Familial partial epilepsy with variable foci in a dutch family:clinical characteristics and confirmation of linkage to chromosome 22q]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2003</year>
<volume>44</volume>
<page-range>1298-305</page-range></nlm-citation>
</ref>
<ref id="B107">
<label>75</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dibbens]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[de Vries]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Donatello]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in DEPDC5 cause familial focal epilepsy with variable foci]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2013</year>
<volume>45</volume>
<page-range>546-51</page-range></nlm-citation>
</ref>
<ref id="B108">
<label>76</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ishida]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Picard]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rudolf]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations of DEPDC5 cause autosomal dominant focal epilepsies]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2013</year>
<volume>45</volume>
<page-range>552-5</page-range></nlm-citation>
</ref>
<ref id="B109">
<label>77</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[O'Brien]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Praveen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Familial focal epilepsy with variable foci mapped to chromosome 22q12:expansion of the phenotypic spectrum]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2012</year>
<volume>53</volume>
<page-range>e151-5</page-range></nlm-citation>
</ref>
<ref id="B110">
<label>78</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Meloche]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rioux]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A recurrent mutation in DEPDC5 predisposes to focal epilepsies in the french-canadian population]]></article-title>
<source><![CDATA[Clin Genet]]></source>
<year>2014</year>
<volume>86</volume>
<page-range>570-4</page-range></nlm-citation>
</ref>
<ref id="B111">
<label>79</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Picard]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Baulac]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kahane]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families]]></article-title>
<source><![CDATA[Brain]]></source>
<year>2000</year>
<volume>123</volume>
<numero>Pt 6</numero>
<issue>Pt 6</issue>
<page-range>1247-62</page-range></nlm-citation>
</ref>
<ref id="B112">
<label>80</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Picard]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Makrythanasis]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Navarro]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[DEPDC5 mutations in families presenting as autosomal dominant nocturnal frontal lobe epilepsy]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2014</year>
<volume>82</volume>
<page-range>2101-6</page-range></nlm-citation>
</ref>
<ref id="B113">
<label>81</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scheffer]]></surname>
<given-names><![CDATA[IE]]></given-names>
</name>
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Regan]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2014</year>
<volume>75</volume>
<page-range>782-7</page-range></nlm-citation>
</ref>
<ref id="B114">
<label>82</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scheffer]]></surname>
<given-names><![CDATA[IE]]></given-names>
</name>
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[HA]]></given-names>
</name>
<name>
<surname><![CDATA[O'Brien]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Familial partial epilepsy with variable foci:a new partial epilepsy syndrome with suggestion of linkage to chromosome 2]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>1998</year>
<volume>44</volume>
<page-range>890-9</page-range></nlm-citation>
</ref>
<ref id="B115">
<label>83</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xiong]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Labuda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>1999</year>
<volume>65</volume>
<page-range>1698-710</page-range></nlm-citation>
</ref>
<ref id="B116">
<label>84</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[K]]></surname>
<given-names><![CDATA[Consortium]]></given-names>
</name>
</person-group>
<collab>Epilepsy Phenome/Genome Project Epi4</collab>
<article-title xml:lang=""><![CDATA[Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2015</year>
<volume>78</volume>
<page-range>323-8</page-range></nlm-citation>
</ref>
<ref id="B117">
<label>85</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boumil]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Letts]]></surname>
<given-names><![CDATA[VA]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A missense mutation in a highly conserved alternate exon of dynamin-1 causes epilepsy in fitful mice]]></article-title>
<source><![CDATA[PLoS Genet]]></source>
<year>2010</year>
<volume>6</volume>
</nlm-citation>
</ref>
<ref id="B118">
<label>86</label><nlm-citation citation-type="journal">
<collab>Deciphering Developmental Disorders Study</collab>
<article-title xml:lang=""><![CDATA[Large-scale discovery of novel genetic causes of developmental disorders]]></article-title>
<source><![CDATA[Nature]]></source>
<year>2015</year>
<volume>519</volume>
<page-range>223-8</page-range></nlm-citation>
</ref>
<ref id="B119">
<label>87</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dhindsa]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Bradrick]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Yao]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epileptic encephalopathy-causing mutations in DNM1 impair synaptic vesicle endocytosis]]></article-title>
<source><![CDATA[Neurol Genet]]></source>
<year>2015</year>
<volume>1</volume>
</nlm-citation>
</ref>
<ref id="B120">
<label>88</label><nlm-citation citation-type="journal">
<collab>EuroEPINOMICS-RES Consortium</collab>
<collab>Epilepsy Phenome/Genome Project, Epi4K Consortium</collab>
<article-title xml:lang=""><![CDATA[De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2014</year>
<volume>95</volume>
<page-range>360-70</page-range></nlm-citation>
</ref>
<ref id="B121">
<label>89</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perrault]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Hamdan]]></surname>
<given-names><![CDATA[FF]]></given-names>
</name>
<name>
<surname><![CDATA[Rio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in DOCK7 in individuals with epileptic encephalopathy and cortical blindness]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2014</year>
<volume>94</volume>
<page-range>891-7</page-range></nlm-citation>
</ref>
<ref id="B122">
<label>90</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvill]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Weckhuysen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[McMahon]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GABRA1 and STXBP1:novel genetic causes of dravet syndrome]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2014</year>
<volume>82</volume>
<page-range>1245-53</page-range></nlm-citation>
</ref>
<ref id="B123">
<label>91</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cossette]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Brisebois]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2002</year>
<volume>31</volume>
<page-range>184-9</page-range></nlm-citation>
</ref>
<ref id="B124">
<label>92</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ding]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Feng]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Macdonald]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GABA(A) receptor alpha1 subunit mutation A322D associated with autosomal dominant juvenile myoclonic epilepsy reduces the expression and alters the composition of wild type GABA(A) receptors]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>2010</year>
<volume>285</volume>
<page-range>26390-405</page-range></nlm-citation>
</ref>
<ref id="B125">
<label>93</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lachance-Touchette]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Brown]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Meloche]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel ?1 and ?2 GABAA receptor subunit mutations in families with idiopathic generalized epilepsy]]></article-title>
<source><![CDATA[Eur J Neurosci]]></source>
<year>2011</year>
<volume>34</volume>
<page-range>237-49</page-range></nlm-citation>
</ref>
<ref id="B126">
<label>94</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maljevic]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Krampfl]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Cobilanschi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A mutation in the GABA(A) receptor alpha(1)-subunit is associated with absence epilepsy]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2006</year>
<volume>59</volume>
<page-range>983-7</page-range></nlm-citation>
</ref>
<ref id="B127">
<label>95</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Olsen]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2008</year>
<volume>82</volume>
<page-range>1249-61</page-range></nlm-citation>
</ref>
<ref id="B128">
<label>96</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Urak]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Feucht]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Fathi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hornik]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fuchs]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity]]></article-title>
<source><![CDATA[Hum Mol Genet]]></source>
<year>2006</year>
<volume>15</volume>
<page-range>2533-41</page-range></nlm-citation>
</ref>
<ref id="B129">
<label>97</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Audenaert]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Claeys]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A novel GABRG2 mutation associated with febrile seizures]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2006</year>
<volume>67</volume>
<page-range>687-90</page-range></nlm-citation>
</ref>
<ref id="B130">
<label>98</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baulac]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Huberfeld]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gourfinkel-An]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[First genetic evidence of GABA(A) receptor dysfunction in epilepsy:a mutation in the gamma2-subunit gene]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2001</year>
<volume>28</volume>
<page-range>46-8</page-range></nlm-citation>
</ref>
<ref id="B131">
<label>99</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chaumont]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[André]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Perrais]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Boué-Grabot]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Agonist-dependent endocytosis of ?-aminobutyric acid Type A (GABAA) receptors revealed by a ?2(R43Q) epilepsy mutation]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>2013</year>
<volume>288</volume>
<page-range>28254-65</page-range></nlm-citation>
</ref>
<ref id="B132">
<label>100</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chiu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Reid]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[HO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Developmental impact of a familial GABAA receptor epilepsy mutation]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2008</year>
<volume>64</volume>
<page-range>284-93</page-range></nlm-citation>
</ref>
<ref id="B133">
<label>101</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frugier]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Coussen]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Giraud]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A gamma 2(R43Q) mutation, linked to epilepsy in humans, alters GABAA receptor assembly and modifies subunit composition on the cell surface]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>2007</year>
<volume>282</volume>
<page-range>3819-28</page-range></nlm-citation>
</ref>
<ref id="B134">
<label>102</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harkin]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
<name>
<surname><![CDATA[Bowser]]></surname>
<given-names><![CDATA[DN]]></given-names>
</name>
<name>
<surname><![CDATA[Dibbens]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Truncation of the GABA(A)-receptor gamma2 subunit in a family with generalized epilepsy with febrile seizures plus]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2002</year>
<volume>70</volume>
<page-range>530-6</page-range></nlm-citation>
</ref>
<ref id="B135">
<label>103</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kananura]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Haug]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Sander]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions]]></article-title>
<source><![CDATA[Arch Neurol]]></source>
<year>2002</year>
<volume>59</volume>
<page-range>1137-41</page-range></nlm-citation>
</ref>
<ref id="B136">
<label>104</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kang]]></surname>
<given-names><![CDATA[JQ]]></given-names>
</name>
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Macdonald]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Why does fever trigger febrile seizures? GABAA receptor gamma2 subunit mutations associated with idiopathic generalized epilepsies have temperature-dependent trafficking deficiencies]]></article-title>
<source><![CDATA[J Neurosci]]></source>
<year>2006</year>
<volume>26</volume>
<page-range>2590-7</page-range></nlm-citation>
</ref>
<ref id="B137">
<label>105</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sancar]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Czajkowski]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A GABAA receptor mutation linked to human epilepsy (gamma2R43Q) impairs cell surface expression of alphabetagamma receptors]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>2004</year>
<volume>279</volume>
<page-range>47034-9</page-range></nlm-citation>
</ref>
<ref id="B138">
<label>106</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[HO]]></given-names>
</name>
<name>
<surname><![CDATA[Reid]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Single]]></surname>
<given-names><![CDATA[FN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reduced cortical inhibition in a mouse model of familial childhood absence epilepsy]]></article-title>
<source><![CDATA[Proc Natl Acad Sci U S A]]></source>
<year>2007</year>
<volume>104</volume>
<page-range>17536-41</page-range></nlm-citation>
</ref>
<ref id="B139">
<label>107</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wallace]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Marini]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Petrou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2001</year>
<volume>28</volume>
<page-range>49-52</page-range></nlm-citation>
</ref>
<ref id="B140">
<label>108</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nakamura]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kodera]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Akita]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo mutations in GNAO1, encoding a g?o subunit of heterotrimeric G proteins, cause epileptic encephalopathy]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2013</year>
<volume>93</volume>
<page-range>496-505</page-range></nlm-citation>
</ref>
<ref id="B141">
<label>109</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvill]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Regan]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Yendle]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GRIN2A mutations cause epilepsy-aphasia spectrum disorders]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2013</year>
<volume>45</volume>
<page-range>1073-6</page-range></nlm-citation>
</ref>
<ref id="B142">
<label>110</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Endele]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenberger]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Geider]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2010</year>
<volume>42</volume>
<page-range>1021-6</page-range></nlm-citation>
</ref>
<ref id="B143">
<label>111</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lesca]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Rudolf]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Bruneau]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GRIN2A mutations in acquired epileptic aphasia and related childhood focal epilepsies and encephalopathies with speech and language dysfunction]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2013</year>
<volume>45</volume>
<page-range>1061-6</page-range></nlm-citation>
</ref>
<ref id="B144">
<label>112</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lemke]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Lal]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Reinthaler]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in GRIN2A cause idiopathic focal epilepsy with rolandic spikes]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2013</year>
<volume>45</volume>
<page-range>1067-72</page-range></nlm-citation>
</ref>
<ref id="B145">
<label>113</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scheffer]]></surname>
<given-names><![CDATA[IE]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pozzebon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autosomal dominant rolandic epilepsy and speech dyspraxia:a new syndrome with anticipation]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>1995</year>
<volume>38</volume>
<page-range>633-42</page-range></nlm-citation>
</ref>
<ref id="B146">
<label>114</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nava]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Dalle]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rastetter]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo mutations in HCN1 cause early infantile epileptic encephalopathy]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2014</year>
<volume>46</volume>
<page-range>640-5</page-range></nlm-citation>
</ref>
<ref id="B147">
<label>115</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bassi]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Balottin]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Panzeri]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC)]]></article-title>
<source><![CDATA[Neurogenetics]]></source>
<year>2005</year>
<volume>6</volume>
<page-range>185-93</page-range></nlm-citation>
</ref>
<ref id="B148">
<label>116</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berkovic]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Kennerson]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Howell]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phenotypic expression of benign familial neonatal convulsions linked to chromosome 20]]></article-title>
<source><![CDATA[Arch Neurol]]></source>
<year>1994</year>
<volume>51</volume>
<page-range>1125-8</page-range></nlm-citation>
</ref>
<ref id="B149">
<label>117</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Biervert]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Schroeder]]></surname>
<given-names><![CDATA[BC]]></given-names>
</name>
<name>
<surname><![CDATA[Kubisch]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A potassium channel mutation in neonatal human epilepsy]]></article-title>
<source><![CDATA[Science]]></source>
<year>1998</year>
<volume>279</volume>
<page-range>403-6</page-range></nlm-citation>
</ref>
<ref id="B150">
<label>118</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Biervert]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Steinlein]]></surname>
<given-names><![CDATA[OK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Structural and mutational analysis of KCNQ2, the major gene locus for benign familial neonatal convulsions]]></article-title>
<source><![CDATA[Hum Genet]]></source>
<year>1999</year>
<volume>104</volume>
<page-range>234-40</page-range></nlm-citation>
</ref>
<ref id="B151">
<label>119</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borgatti]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Zucca]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cavallini]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2004</year>
<volume>63</volume>
<page-range>57-65</page-range></nlm-citation>
</ref>
<ref id="B152">
<label>120</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dedek]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Fusco]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Teloy]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Steinlein]]></surname>
<given-names><![CDATA[OK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neonatal convulsions and epileptic encephalopathy in an italian family with a missense mutation in the fifth transmembrane region of KCNQ2]]></article-title>
<source><![CDATA[Epilepsy Res]]></source>
<year>2003</year>
<volume>54</volume>
<page-range>21-7</page-range></nlm-citation>
</ref>
<ref id="B153">
<label>121</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[del]]></surname>
<given-names><![CDATA[Giudice EM]]></given-names>
</name>
<name>
<surname><![CDATA[Coppola]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Scuccimarra]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benign familial neonatal convulsions (BFNC) resulting from mutation of the KCNQ2 voltage sensor]]></article-title>
<source><![CDATA[Eur J Hum Genet]]></source>
<year>2000</year>
<volume>8</volume>
<page-range>994-7</page-range></nlm-citation>
</ref>
<ref id="B154">
<label>122</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Cox]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Grinton]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures]]></article-title>
<source><![CDATA[J Med Genet]]></source>
<year>2007</year>
<volume>44</volume>
<page-range>791-6</page-range></nlm-citation>
</ref>
<ref id="B155">
<label>123</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saitsu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Kato]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Koide]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Whole exome sequencing identifies KCNQ2 mutations in ohtahara syndrome]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2012</year>
<volume>72</volume>
<page-range>298-300</page-range></nlm-citation>
</ref>
<ref id="B156">
<label>124</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Singh]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Charlier]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Stauffer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>1998</year>
<volume>18</volume>
<page-range>25-9</page-range></nlm-citation>
</ref>
<ref id="B157">
<label>125</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weckhuysen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mandelstam]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Suls]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[KCNQ2 encephalopathy:emerging phenotype of a neonatal epileptic encephalopathy]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2012</year>
<volume>71</volume>
<page-range>15-25</page-range></nlm-citation>
</ref>
<ref id="B158">
<label>126</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wuttke]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
<name>
<surname><![CDATA[Jurkat-Rott]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Paulus]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2007</year>
<volume>69</volume>
<page-range>2045-53</page-range></nlm-citation>
</ref>
<ref id="B159">
<label>127</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[WP]]></given-names>
</name>
<name>
<surname><![CDATA[Levesque]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
<name>
<surname><![CDATA[Little]]></surname>
<given-names><![CDATA[WA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Functional expression of two kvLQT1-related potassium channels responsible for an inherited idiopathic epilepsy]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>1998</year>
<volume>273</volume>
<page-range>19419-23</page-range></nlm-citation>
</ref>
<ref id="B160">
<label>128</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zimprich]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ronen]]></surname>
<given-names><![CDATA[GM]]></given-names>
</name>
<name>
<surname><![CDATA[Stögmann]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Andreas rett and benign familial neonatal convulsions revisited]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2006</year>
<volume>67</volume>
<page-range>864-6</page-range></nlm-citation>
</ref>
<ref id="B161">
<label>129</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barcia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Fleming]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Deligniere]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2012</year>
<volume>44</volume>
<page-range>1255-9</page-range></nlm-citation>
</ref>
<ref id="B162">
<label>130</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Derry]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Severe autosomal dominant nocturnal frontal lobe epilepsy associated with psychiatric disorders and intellectual disability]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2008</year>
<volume>49</volume>
<page-range>2125-9</page-range></nlm-citation>
</ref>
<ref id="B163">
<label>131</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[Bahlo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2012</year>
<volume>44</volume>
<page-range>1188-90</page-range></nlm-citation>
</ref>
<ref id="B164">
<label>132</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ishii]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Shioda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Okumura]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy]]></article-title>
<source><![CDATA[Gene]]></source>
<year>2013</year>
<volume>531</volume>
<page-range>467-71</page-range></nlm-citation>
</ref>
<ref id="B165">
<label>133</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ohba]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kato]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early onset epileptic encephalopathy caused by de novo SCN8A mutations]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2014</year>
<volume>55</volume>
<page-range>994-1000</page-range></nlm-citation>
</ref>
<ref id="B166">
<label>134</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vanderver]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Simons]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Schmidt]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identification of a novel de novo p.Ph.e932Ile KCNT1 mutation in a patient with leukoencephalopathy and severe epilepsy]]></article-title>
<source><![CDATA[Pediatr Neurol]]></source>
<year>2014</year>
<volume>50</volume>
<page-range>112-4</page-range></nlm-citation>
</ref>
<ref id="B167">
<label>135</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chabrol]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Popescu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Gourfinkel-An]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Two novel epilepsy-linked mutations leading to a loss of function of LGI1]]></article-title>
<source><![CDATA[Arch Neurol]]></source>
<year>2007</year>
<volume>64</volume>
<page-range>217-22</page-range></nlm-citation>
</ref>
<ref id="B168">
<label>136</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fanciulli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Santulli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Errichiello]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[LGI1 microdeletion in autosomal dominant lateral temporal epilepsy]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2012</year>
<volume>78</volume>
<page-range>1299-303</page-range></nlm-citation>
</ref>
<ref id="B169">
<label>137</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fertig]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lincoln]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Martinuzzi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mattson]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Hisama]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel LGI1 mutation in a family with autosomal dominant partial epilepsy with auditory features]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2003</year>
<volume>60</volume>
<page-range>1687-90</page-range></nlm-citation>
</ref>
<ref id="B170">
<label>138</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kalachikov]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Evgrafov]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Ross]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2002</year>
<volume>30</volume>
<page-range>335-41</page-range></nlm-citation>
</ref>
<ref id="B171">
<label>139</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morante-Redolat]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Gorostidi-Pagola]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Piquer-Sirerol]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in the LGI1/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy]]></article-title>
<source><![CDATA[Hum Mol Genet]]></source>
<year>2002</year>
<volume>11</volume>
<page-range>1119-28</page-range></nlm-citation>
</ref>
<ref id="B172">
<label>140</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nobile]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Michelucci]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Andreazza]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy]]></article-title>
<source><![CDATA[Hum Mutat]]></source>
<year>2009</year>
<volume>30</volume>
<page-range>530-6</page-range></nlm-citation>
</ref>
<ref id="B173">
<label>141</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sirerol-Piquer]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Ayerdi-Izquierdo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Morante-Redolat]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface]]></article-title>
<source><![CDATA[Hum Mol Genet]]></source>
<year>2006</year>
<volume>15</volume>
<page-range>3436-45</page-range></nlm-citation>
</ref>
<ref id="B174">
<label>142</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Striano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[de]]></surname>
<given-names><![CDATA[Falco A]]></given-names>
</name>
<name>
<surname><![CDATA[Diani]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A novel loss-of-function LGI1 mutation linked to autosomal dominant lateral temporal epilepsy]]></article-title>
<source><![CDATA[Arch Neurol]]></source>
<year>2008</year>
<volume>65</volume>
<page-range>939-42</page-range></nlm-citation>
</ref>
<ref id="B175">
<label>143</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Depienne]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bouteiller]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Keren]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles dravet syndrome but mainly affects females]]></article-title>
<source><![CDATA[PLoS Genet]]></source>
<year>2009</year>
<volume>5</volume>
</nlm-citation>
</ref>
<ref id="B176">
<label>144</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dibbens]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Tarpey]]></surname>
<given-names><![CDATA[PS]]></given-names>
</name>
<name>
<surname><![CDATA[Hynes]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2008</year>
<volume>40</volume>
<page-range>776-81</page-range></nlm-citation>
</ref>
<ref id="B177">
<label>145</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hynes]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Tarpey]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Dibbens]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epilepsy and mental retardation limited to females with PCDH19 mutations can present de novo or in single generation families]]></article-title>
<source><![CDATA[J Med Genet]]></source>
<year>2010</year>
<volume>47</volume>
<page-range>211-6</page-range></nlm-citation>
</ref>
<ref id="B178">
<label>146</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kurian]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Meyer]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Vassallo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy]]></article-title>
<source><![CDATA[Brain]]></source>
<year>2010</year>
<volume>133</volume>
<page-range>2964-70</page-range></nlm-citation>
</ref>
<ref id="B179">
<label>147</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poduri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chopra]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Neilan]]></surname>
<given-names><![CDATA[EG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Homozygous PLCB1 deletion associated with malignant migrating partial seizures in infancy]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2012</year>
<volume>53</volume>
<page-range>e146-50</page-range></nlm-citation>
</ref>
<ref id="B180">
<label>148</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gilmore]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Marshall]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in PNKP cause microcephaly, seizures and defects in DNA repair]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2010</year>
<volume>42</volume>
<page-range>245-9</page-range></nlm-citation>
</ref>
<ref id="B181">
<label>149</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Xiong]]></surname>
<given-names><![CDATA[ZQ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2011</year>
<volume>43</volume>
<page-range>1252-5</page-range></nlm-citation>
</ref>
<ref id="B182">
<label>150</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Grinton]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Kivity]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2012</year>
<volume>90</volume>
<page-range>152-60</page-range></nlm-citation>
</ref>
<ref id="B183">
<label>151</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Bruneau]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions]]></article-title>
<source><![CDATA[Cell Rep]]></source>
<year>2012</year>
<volume>1</volume>
<page-range>2-12</page-range></nlm-citation>
</ref>
<ref id="B184">
<label>152</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Méneret]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Grabli]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Depienne]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PRRT2 mutations:a major cause of paroxysmal kinesigenic dyskinesia in the European population]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2012</year>
<volume>79</volume>
<page-range>170-4</page-range></nlm-citation>
</ref>
<ref id="B185">
<label>153</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ono]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshiura]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kinoshita]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also cause benign familial infantile convulsions]]></article-title>
<source><![CDATA[J Hum Genet]]></source>
<year>2012</year>
<volume>57</volume>
<page-range>338-41</page-range></nlm-citation>
</ref>
<ref id="B186">
<label>154</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pelzer]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[de]]></surname>
<given-names><![CDATA[Vries B]]></given-names>
</name>
<name>
<surname><![CDATA[Kamphorst]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PRRT2 and hemiplegic migraine:a complex association]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2014</year>
<volume>83</volume>
<page-range>288-90</page-range></nlm-citation>
</ref>
<ref id="B187">
<label>155</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schubert]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Paravidino]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Becker]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PRRT2 mutations are the major cause of benign familial infantile seizures]]></article-title>
<source><![CDATA[Hum Mutat]]></source>
<year>2012</year>
<volume>33</volume>
<page-range>1439-43</page-range></nlm-citation>
</ref>
<ref id="B188">
<label>156</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Striano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Lispi]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Gennaro]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linkage analysis and disease models in benign familial infantile seizures:a study of 16 families]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2006</year>
<volume>47</volume>
<page-range>1029-34</page-range></nlm-citation>
</ref>
<ref id="B189">
<label>157</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Cao]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[XH]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[ZM]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias]]></article-title>
<source><![CDATA[Brain]]></source>
<year>2011</year>
<volume>134</volume>
<page-range>3493-501</page-range></nlm-citation>
</ref>
<ref id="B190">
<label>158</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[YG]]></given-names>
</name>
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bebek]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benign familial infantile convulsions:linkage to chromosome 16p12-q12 in 14 families]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2004</year>
<volume>45</volume>
<page-range>601-9</page-range></nlm-citation>
</ref>
<ref id="B191">
<label>159</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abou-Khalil]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Ge]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Desai]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2001</year>
<volume>57</volume>
<page-range>2265-72</page-range></nlm-citation>
</ref>
<ref id="B192">
<label>160</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baulac]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gourfinkel-An]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Picard]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>1999</year>
<volume>65</volume>
<page-range>1078-85</page-range></nlm-citation>
</ref>
<ref id="B193">
<label>161</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Buoni]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Orrico]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Galli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[SCN1A (2528delG) novel truncating mutation with benign outcome of severe myoclonic epilepsy of infancy]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2006</year>
<volume>66</volume>
<page-range>606-7</page-range></nlm-citation>
</ref>
<ref id="B194">
<label>162</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rojo]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Hamiwka]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[McMahon]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo SCN1A mutations in migrating partial seizures of infancy]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2011</year>
<volume>77</volume>
<page-range>380-3</page-range></nlm-citation>
</ref>
<ref id="B195">
<label>163</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Claes]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Del-Favero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ceulemans]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2001</year>
<volume>68</volume>
<page-range>1327-32</page-range></nlm-citation>
</ref>
<ref id="B196">
<label>164</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dichgans]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Freilinger]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Eckstein]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2005</year>
<volume>366</volume>
<page-range>371-7</page-range></nlm-citation>
</ref>
<ref id="B197">
<label>165</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Escayg]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[MacDonald]]></surname>
<given-names><![CDATA[BT]]></given-names>
</name>
<name>
<surname><![CDATA[Meisler]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2000</year>
<volume>24</volume>
<page-range>343-5</page-range></nlm-citation>
</ref>
<ref id="B198">
<label>166</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Freilich]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Gaillard]]></surname>
<given-names><![CDATA[WD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel SCN1A mutation in a proband with malignant migrating partial seizures of infancy]]></article-title>
<source><![CDATA[Arch Neurol]]></source>
<year>2011</year>
<volume>68</volume>
<page-range>665-71</page-range></nlm-citation>
</ref>
<ref id="B199">
<label>167</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mantegazza]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gambardella]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rusconi]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identification of an nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures]]></article-title>
<source><![CDATA[Proc Natl Acad Sci U S A]]></source>
<year>2005</year>
<volume>102</volume>
<page-range>18177-82</page-range></nlm-citation>
</ref>
<ref id="B200">
<label>168</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McArdle]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kunic]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[George Jr]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel SCN1A frameshift mutation with absence of truncated nav1.1 protein in severe myoclonic epilepsy of infancy]]></article-title>
<source><![CDATA[Am J Med Genet A]]></source>
<year>2008</year>
<volume>146A</volume>
<page-range>2421-3</page-range></nlm-citation>
</ref>
<ref id="B201">
<label>169</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moulard]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Buresi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Malafosse]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Study of the voltage-gated sodium channel beta 1 subunit gene (SCN1B) in the benign familial infantile convulsions syndrome (BFIC)]]></article-title>
<source><![CDATA[Hum Mutat]]></source>
<year>2000</year>
<volume>16</volume>
<page-range>139-42</page-range></nlm-citation>
</ref>
<ref id="B202">
<label>170</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mulley]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Scheffer]]></surname>
<given-names><![CDATA[IE]]></given-names>
</name>
<name>
<surname><![CDATA[Petrou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[SCN1A mutations and epilepsy]]></article-title>
<source><![CDATA[Hum Mutat]]></source>
<year>2005</year>
<volume>25</volume>
<page-range>535-42</page-range></nlm-citation>
</ref>
<ref id="B203">
<label>171</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ohmori]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ouchida]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ohtsuka]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Oka]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Shimizu]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy]]></article-title>
<source><![CDATA[Biochem Biophys Res Commun]]></source>
<year>2002</year>
<volume>295</volume>
<page-range>17-23</page-range></nlm-citation>
</ref>
<ref id="B204">
<label>172</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Orrico]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Galli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Grosso]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutational analysis of the SCN1A, SCN1B and GABRG2 genes in 150 italian patients with idiopathic childhood epilepsies]]></article-title>
<source><![CDATA[Clin Genet]]></source>
<year>2009</year>
<volume>75</volume>
<page-range>579-81</page-range></nlm-citation>
</ref>
<ref id="B205">
<label>173</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petrovski]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Scheffer]]></surname>
<given-names><![CDATA[IE]]></given-names>
</name>
<name>
<surname><![CDATA[Sisodiya]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lack of replication of association between scn1a SNP and febrile seizures]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2009</year>
<volume>73</volume>
<page-range>1928-30</page-range></nlm-citation>
</ref>
<ref id="B206">
<label>174</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schlachter]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Gruber-Sedlmayr]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Stogmann]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A splice site variant in the sodium channel gene SCN1A confers risk of febrile seizures]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2009</year>
<volume>72</volume>
<page-range>974-8</page-range></nlm-citation>
</ref>
<ref id="B207">
<label>175</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vahedi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Depienne]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Le]]></surname>
<given-names><![CDATA[Fort D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Elicited repetitive daily blindness:a new phenotype associated with hemiplegic migraine and SCN1A mutations]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2009</year>
<volume>72</volume>
<page-range>1178-83</page-range></nlm-citation>
</ref>
<ref id="B208">
<label>176</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zucca]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Redaelli]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Epifanio]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cryptogenic epileptic syndromes related to SCN1A:twelve novel mutations identified]]></article-title>
<source><![CDATA[Arch Neurol]]></source>
<year>2008</year>
<volume>65</volume>
<page-range>489-94</page-range></nlm-citation>
</ref>
<ref id="B209">
<label>177</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berkovic]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Giordano]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benign familial neonatal-infantile seizures:characterization of a new sodium channelopathy]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2004</year>
<volume>55</volume>
<page-range>550-7</page-range></nlm-citation>
</ref>
<ref id="B210">
<label>178</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heron]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Crossland]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Andermann]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sodium-channel defects in benign familial neonatal-infantile seizures]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2002</year>
<volume>360</volume>
<page-range>851-2</page-range></nlm-citation>
</ref>
<ref id="B211">
<label>179</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kamiya]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kaneda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sugawara]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline]]></article-title>
<source><![CDATA[J Neurosci]]></source>
<year>2004</year>
<volume>24</volume>
<page-range>2690-8</page-range></nlm-citation>
</ref>
<ref id="B212">
<label>180</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liao]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Anttonen]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Liukkonen]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2010</year>
<volume>75</volume>
<page-range>1454-8</page-range></nlm-citation>
</ref>
<ref id="B213">
<label>181</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malacarne]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gennaro]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Madia]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Benign familial infantile convulsions:mapping of a novel locus on chromosome 2q24 and evidence for genetic heterogeneity]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2001</year>
<volume>68</volume>
<page-range>1521-6</page-range></nlm-citation>
</ref>
<ref id="B214">
<label>182</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ogiwara]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Ito]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Sawaishi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2009</year>
<volume>73</volume>
<page-range>1046-53</page-range></nlm-citation>
</ref>
<ref id="B215">
<label>183</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sugawara]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tsurubuchi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Agarwala]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A missense mutation of the na+channel alpha II subunit gene na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction]]></article-title>
<source><![CDATA[Proc Natl Acad Sci U S A]]></source>
<year>2001</year>
<volume>98</volume>
<page-range>6384-9</page-range></nlm-citation>
</ref>
<ref id="B216">
<label>184</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blanchard]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
<name>
<surname><![CDATA[Willemsen]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy]]></article-title>
<source><![CDATA[J Med Genet]]></source>
<year>2015</year>
<volume>52</volume>
<page-range>330-7</page-range></nlm-citation>
</ref>
<ref id="B217">
<label>185</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[de]]></surname>
<given-names><![CDATA[Kovel CG]]></given-names>
</name>
<name>
<surname><![CDATA[Meisler]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Brilstra]]></surname>
<given-names><![CDATA[EH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characterization of a de novo SCN8A mutation in a patient with epileptic encephalopathy]]></article-title>
<source><![CDATA[Epilepsy Res]]></source>
<year>2014</year>
<volume>108</volume>
<page-range>1511-8</page-range></nlm-citation>
</ref>
<ref id="B218">
<label>186</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Veeramah]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[O'Brien]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Meisler]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2012</year>
<volume>90</volume>
<page-range>502-10</page-range></nlm-citation>
</ref>
<ref id="B219">
<label>187</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arsov]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Mullen]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Rogers]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glucose transporter 1 deficiency in the idiopathic generalized epilepsies]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2012</year>
<volume>72</volume>
<page-range>807-15</page-range></nlm-citation>
</ref>
<ref id="B220">
<label>188</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Striano]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[YG]]></given-names>
</name>
<name>
<surname><![CDATA[Toliat]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GLUT1 muations are a rare cause of familial idiopathic generalized epilepsy]]></article-title>
<source><![CDATA[Neurology]]></source>
<year>2012</year>
<volume>78</volume>
<page-range>557-62</page-range></nlm-citation>
</ref>
<ref id="B221">
<label>189</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Suls]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mullen]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[YG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early-onset absence epilepsy caused by mutations in the glucose transporter GLUT1]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2009</year>
<volume>66</volume>
<page-range>415-9</page-range></nlm-citation>
</ref>
<ref id="B222">
<label>190</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Molinari]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Raas-Rothschild]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2005</year>
<volume>76</volume>
<page-range>334-9</page-range></nlm-citation>
</ref>
<ref id="B223">
<label>191</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Poduri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Heinzen]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Chitsazzadeh]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[SLC25A22 is a novel gene for migrating partial seizures in infancy]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2013</year>
<volume>74</volume>
<page-range>873-82</page-range></nlm-citation>
</ref>
<ref id="B224">
<label>192</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hamdan]]></surname>
<given-names><![CDATA[FF]]></given-names>
</name>
<name>
<surname><![CDATA[Saitsu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nishiyama]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy]]></article-title>
<source><![CDATA[Eur J Hum Genet]]></source>
<year>2012</year>
<volume>20</volume>
<page-range>796-800</page-range></nlm-citation>
</ref>
<ref id="B225">
<label>193</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nonoda]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Saito]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Nagai]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Progressive diffuse brain atrophy in west syndrome with marked hypomyelination due to SPTAN1 gene mutation]]></article-title>
<source><![CDATA[Brain Dev]]></source>
<year>2013</year>
<volume>35</volume>
<page-range>280-3</page-range></nlm-citation>
</ref>
<ref id="B226">
<label>194</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saitsu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Tohyama]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kumada]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dominant-negative mutations in alpha-II spectrin cause west syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2010</year>
<volume>86</volume>
<page-range>881-91</page-range></nlm-citation>
</ref>
<ref id="B227">
<label>195</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hamdan]]></surname>
<given-names><![CDATA[FF]]></given-names>
</name>
<name>
<surname><![CDATA[Piton]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gauthier]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2009</year>
<volume>65</volume>
<page-range>748-53</page-range></nlm-citation>
</ref>
<ref id="B228">
<label>196</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saitsu]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Kato]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mizuguchi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy]]></article-title>
<source><![CDATA[Nat Genet]]></source>
<year>2008</year>
<volume>40</volume>
<page-range>782-8</page-range></nlm-citation>
</ref>
<ref id="B229">
<label>197</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Edvardson]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Baumann]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Mühlenhoff]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[West syndrome caused by ST3Gal-III deficiency]]></article-title>
<source><![CDATA[Epilepsia]]></source>
<year>2013</year>
<volume>54</volume>
<page-range>e24-7</page-range></nlm-citation>
</ref>
<ref id="B230">
<label>198</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Berryer]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Hamdan]]></surname>
<given-names><![CDATA[FF]]></given-names>
</name>
<name>
<surname><![CDATA[Klitten]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency]]></article-title>
<source><![CDATA[Hum Mutat]]></source>
<year>2013</year>
<volume>34</volume>
<page-range>385-94</page-range></nlm-citation>
</ref>
<ref id="B231">
<label>199</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mignot]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[von]]></surname>
<given-names><![CDATA[Stülpnagel C]]></given-names>
</name>
<name>
<surname><![CDATA[Nava]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genetic and neurodevelopmental spectrum of SYNGAP1-associated intellectual disability and epilepsy]]></article-title>
<source><![CDATA[J Med Genet]]></source>
<year>2016</year>
<volume>53</volume>
<page-range>511-22</page-range></nlm-citation>
</ref>
<ref id="B232">
<label>200</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basel-Vanagaite]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hershkovitz]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Heyman]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biallelic SZT2 mutations cause infantile encephalopathy with epilepsy and dysmorphic corpus callosum]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2013</year>
<volume>93</volume>
<page-range>524-9</page-range></nlm-citation>
</ref>
<ref id="B233">
<label>201</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Corbett]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Bahlo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jolly]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2010</year>
<volume>87</volume>
<page-range>371-5</page-range></nlm-citation>
</ref>
<ref id="B234">
<label>202</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duru]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Iseri]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Selçuk]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Tolun]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early-onset progressive myoclonic epilepsy with dystonia mapping to 16pter-p13.3]]></article-title>
<source><![CDATA[J Neurogenet]]></source>
<year>2010</year>
<volume>24</volume>
<page-range>207-15</page-range></nlm-citation>
</ref>
<ref id="B235">
<label>203</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Falace]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Filipello]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[La]]></surname>
<given-names><![CDATA[Padula V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2010</year>
<volume>87</volume>
<page-range>365-70</page-range></nlm-citation>
</ref>
<ref id="B236">
<label>204</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guven]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tolun]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[TBC1D24 truncating mutation resulting in severe neurodegeneration]]></article-title>
<source><![CDATA[J Med Genet]]></source>
<year>2013</year>
<volume>50</volume>
<page-range>199-202</page-range></nlm-citation>
</ref>
<ref id="B237">
<label>205</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Milh]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Falace]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Villeneuve]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy]]></article-title>
<source><![CDATA[Hum Mutat]]></source>
<year>2013</year>
<volume>34</volume>
<page-range>869-72</page-range></nlm-citation>
</ref>
<ref id="B238">
<label>206</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zara]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Gennaro]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Stabile]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Mapping of a locus for a familial autosomal recessive idiopathic myoclonic epilepsy of infancy to chromosome 16p13]]></article-title>
<source><![CDATA[Am J Hum Genet]]></source>
<year>2000</year>
<volume>66</volume>
<page-range>1552-7</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
